MPS Pharmaa Limited (BOM:531686)
India · Delayed Price · Currency is INR 1.990
0.00 (0.00%)
At close: Aug 17, 2026
MPS Pharmaa Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | - | - | - | - | - | 0.32 |
Other Revenue | 0.36 | 0.36 | 0.48 | 0.94 | 0.23 | 0 |
| 0.36 | 0.36 | 0.48 | 0.94 | 0.23 | 0.33 | |
Revenue Growth | -18.54% | -25.40% | -49.05% | 302.00% | -28.85% | - |
Cost of Revenue | - | - | 0.18 | 0.28 | 2.09 | 0.61 |
Gross Profit | 0.36 | 0.36 | 0.3 | 0.66 | -1.86 | -0.28 |
Selling, General & Admin | 5.45 | 5.33 | 5.29 | 5.32 | 4.96 | 4.26 |
Other Operating Expenses | 2.58 | 2.59 | 2.17 | 2.39 | 2.43 | 2.19 |
Operating Expenses | 9.48 | 9.39 | 8.92 | 9.17 | 8.84 | 11.59 |
Operating Income | -9.12 | -9.03 | -8.63 | -8.51 | -10.7 | -11.86 |
Interest Expense | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
Interest & Investment Income | - | - | - | - | - | 0.04 |
Other Non Operating Income (Expenses) | -1.54 | -1.54 | -0 | -0.01 | -0.01 | -0.01 |
EBT Excluding Unusual Items | -10.67 | -10.58 | -8.64 | -8.53 | -10.71 | -11.86 |
Other Unusual Items | - | - | - | - | - | 2.54 |
Pretax Income | -10.67 | -10.58 | -8.64 | -8.53 | -10.71 | -9.32 |
Income Tax Expense | -0.29 | -0.38 | 0.34 | -0.22 | -0.21 | -7.91 |
Net Income | -10.38 | -10.2 | -8.98 | -8.31 | -10.5 | -1.42 |
Net Income to Common | -10.38 | -10.2 | -8.98 | -8.31 | -10.5 | -1.42 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 19 | 19 | 19 | 19 | 19 |
Shares Outstanding (Diluted) | 20 | 19 | 19 | 19 | 19 | 19 |
Shares Change | 2.95% | 0.70% | - | - | - | - |
EPS (Basic) | -0.53 | -0.53 | -0.47 | -0.43 | -0.55 | -0.07 |
EPS (Diluted) | -0.53 | -0.53 | -0.47 | -0.43 | -0.55 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | - | -5.9 | -5.7 | -6.5 | -9.83 | -43.52 |
Free Cash Flow Per Share | - | -0.31 | -0.30 | -0.34 | -0.51 | -2.28 |
Gross Margin | 100.00% | 100.00% | 62.49% | 70.12% | - | -85.02% |
Operating Margin | -2562.64% | -2537.64% | -1807.60% | -908.98% | -4591.68% | -3623.19% |
Profit Margin | -2915.45% | -2865.17% | -1881.58% | -887.23% | -4508.10% | -432.36% |
Free Cash Flow Margin | - | -1656.74% | -1194.34% | -694.10% | -4218.27% | -13289.06% |
EBITDA | -7.65 | -7.57 | -7.16 | -7.05 | -9.24 | -6.73 |
D&A For EBITDA | 1.47 | 1.47 | 1.47 | 1.47 | 1.46 | 5.14 |
EBIT | -9.12 | -9.03 | -8.63 | -8.51 | -10.7 | -11.86 |
Revenue as Reported | 0.36 | 0.36 | 0.48 | 0.94 | 0.23 | 2.91 |
Advertising Expenses | - | - | 0.04 | 0.04 | 0.08 | 0.05 |